San Luis Wealth Advisors LLC Has $4.09 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

San Luis Wealth Advisors LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 10.7% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,991 shares of the healthcare conglomerate’s stock after selling 834 shares during the quarter. San Luis Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $4,087,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Macroview Investment Management LLC raised its stake in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares in the last quarter. Delos Wealth Advisors LLC grew its holdings in shares of UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares during the last quarter. Bbjs Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the second quarter worth about $31,000. Global Wealth Strategies & Associates grew its holdings in shares of UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the last quarter. Finally, Signature Resources Capital Management LLC grew its holdings in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $597.68 on Friday. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94. The stock’s 50 day moving average is $583.48 and its 200-day moving average is $530.04. The firm has a market capitalization of $551.91 billion, a price-to-earnings ratio of 39.63, a PEG ratio of 1.65 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. UnitedHealth Group’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm earned $6.14 earnings per share. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.41%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s payout ratio is currently 55.70%.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on UNH shares. HSBC boosted their price target on UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. TD Cowen upped their target price on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a report on Tuesday, October 1st. KeyCorp assumed coverage on UnitedHealth Group in a report on Friday. They issued an “overweight” rating and a $675.00 target price on the stock. Finally, Morgan Stanley upped their target price on UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $617.37.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.